BPPV With CRP: Single Versus Multiple Cycles

Sponsor
Chiang Mai University (Other)
Overall Status
Unknown status
CT.gov ID
NCT02701218
Collaborator
(none)
114
1
2
46
2.5

Study Details

Study Description

Brief Summary

Unilateral posterior canal benign paroxysmal positional vertigo (BPPV) cases will be randomized to treat with single or multiple cycles of canalith repositioning procedure.The treatment outcomes will be assessed at 7th and 28th days.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Canalith repositioning procedure
N/A

Detailed Description

Patients present with brief episodes of vertigo will be evaluated by Dix-Hallpike test. Cases with positive Dix-Hallpike test, unilateral, posterior canal, will be randomized with block of four. Either single or multiple cycles of canalith repositioning procedure will be performed. Four treatment outcomes will be blindly assessed at 7 and 28 days.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
114 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Comparison of the Treatment Outcomes of Posterior Canal Benign Paroxysmal Positional Vertigo (BPPV) With Canalith Repositioning Procedure (CRP): Single Versus Multiple Cycles
Actual Study Start Date :
Feb 1, 2016
Actual Primary Completion Date :
Mar 1, 2019
Anticipated Study Completion Date :
Dec 1, 2019

Arms and Interventions

Arm Intervention/Treatment
Experimental: Single cycle

single cycle of canalith repositioning procedure

Procedure: Canalith repositioning procedure
Canalith repositioning procedure; single or multiple cycles
Other Names:
  • Epley's maneuver
  • Experimental: multiple cycles of CRP

    multiple cycles of canalith repositioning procedure CRP will be stopped if 1) no nystagmus and vertigo in all positions 2) complications exited 3) stable nystagmus in the 2 last cycles

    Procedure: Canalith repositioning procedure
    Canalith repositioning procedure; single or multiple cycles
    Other Names:
  • Epley's maneuver
  • Outcome Measures

    Primary Outcome Measures

    1. Dix-Hallpike test (DHT) [At 7th day]

      percentage of negative DHT between single and multiple cycles

    Secondary Outcome Measures

    1. Dizziness handicap inventory (DHI) [compare to the first visit at 7th between single and multiple cycles]

      total score in the questionaire

    2. Dizziness handicap inventory (DHI) [compare to the first visit at 28th day between single and multiple cycles]

      total score in the questionaire

    3. Subjective symptoms [Improvement of the symptoms compare to the first visit at 7th day between single and multiple cycles]

      Asking the patient's symptom: Improve, same, worse

    4. Subjective symptoms [Improvement of the symptoms compare to the first visit at 28th day between single and multiple cycles]

      Asking the patient's symptom: Improve, same, worse

    5. Loss of balance [compare to the first visit at 7th between single and multiple cycles]

      5 levels Level 1: Able to continue daily activities without any helps. Level 2: Able to continue daily activities without any helps except complicated activities such as riding a bicycle, walking on counterpoise or scaffolding. Level 3: Not able to continue daily activities without help excepts simple activities such as self-care, housework, walking, or being a passenger in a vehicle Level 4: Not able to continue daily activities alone without help except self-care Level 5 Not able to continue daily activities alone without help except self-care without ambulation. Need to stay only in a house or a living place. (From: The Royal college of Otolaryngologists head and neck surgeons of Thailand, and social security office of thailand)

    6. Loss of balance [compare to the first visit at 28th day between single and multiple cycles]

      5 levels Level 1: Able to continue daily activities without any helps. Level 2: Able to continue daily activities without any helps except complicated activities such as riding a bicycle, walking on counterpoise or scaffolding. Level 3: Not able to continue daily activities without help excepts simple activities such as self-care, housework, walking, or being a passenger in a vehicle Level 4: Not able to continue daily activities alone without help except self-care Level 5 Not able to continue daily activities alone without help except self-care without ambulation. Need to stay only in a house or a living place. (From: The Royal college of Otolaryngologists head and neck surgeons of Thailand, and social security office of thailand)

    7. Dix-Hallpike test (DHT) [At 28th day]

      percentage of negative DHT between single and multiple cycles

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    15 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    1. Recurrent episodes of vertigo

    2. 15 years of age or older

    3. Positive Dix-Hallpike test: unilateral, posterior canal

    Exclusion Criteria:
    1. Received vestibular suppressant within 6 hours

    2. With other diseases or conditions cause of vertigo or central nervous system disease

    3. With diseases or conditions contraindicate for Dix-Hallpike test or CRP eg: cervical spine disease, back/ neck stiffness, retinal detachment

    4. Positive Dix-Hallpike test: bilateral, other canals

    5. Complications from CRP eg: nausea, vomiting, canalith jam

    6. Cannot read the questionaire

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Department of Otolaryngology Faculty of Medicine, Chiang Mai University 110 Intawaroros Road, Sriphum Chiang Mai Thailand 50200

    Sponsors and Collaborators

    • Chiang Mai University

    Investigators

    • Principal Investigator: Suwicha I Kaewsiri, MD, Department of Otolaryngology

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Suwicha Isaradisaikul Kaewsiri, Principal Investigator, Clinical Professor, Chiang Mai University
    ClinicalTrials.gov Identifier:
    NCT02701218
    Other Study ID Numbers:
    • ENT-2558-03601
    First Posted:
    Mar 8, 2016
    Last Update Posted:
    Jul 31, 2019
    Last Verified:
    Jul 1, 2019
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Keywords provided by Suwicha Isaradisaikul Kaewsiri, Principal Investigator, Clinical Professor, Chiang Mai University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jul 31, 2019